Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: the ACCENTUATE trial

Simple item page
dc.contributor.authorNicholls, S.
dc.contributor.authorRay, K.
dc.contributor.authorBallantyne, C.
dc.contributor.authorBeacham, L.
dc.contributor.authorMiller, D.
dc.contributor.authorRuotolo, G.
dc.contributor.authorNissen, S.
dc.contributor.authorRiesmeyer, J.
dc.date.issued2017
dc.description.abstractAbstract not available
dc.description.statementofresponsibilityStephen J. Nicholls, Kausik K. Ray, Christie M. Ballantyne, Lauren A. Beacham, Debra L. Miller, Giacomo Ruotolo, Steven E. Nissen, Jeffrey S. Riesmeyer (for theACCENTUATE Investigators)
dc.identifier.citationAtherosclerosis, 2017; 261:12-18
dc.identifier.doi10.1016/j.atherosclerosis.2017.04.008
dc.identifier.issn0021-9150
dc.identifier.issn1879-1484
dc.identifier.orcidNicholls, S. [0000-0002-9668-4368]
dc.identifier.urihttp://hdl.handle.net/2440/115941
dc.language.isoen
dc.publisherElsevier
dc.rights© 2017 Elsevier B.V. All rights reserved.
dc.source.urihttps://doi.org/10.1016/j.atherosclerosis.2017.04.008
dc.subjectCETP; clinical trials; lipids; cardiovascular disease
dc.titleComparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: the ACCENTUATE trial
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications